TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life
Sign Up to like & getrecommendations! Published in 2023 at "mAbs"
DOI: 10.1080/19420862.2022.2160229
Abstract: ABSTRACT TrYbe® is an Fc-free therapeutic antibody format, capable of engaging up to three targets simultaneously, with long in vivo half-life conferred by albumin binding. This format is shown by small-angle X-ray scattering to be… read more here.
Keywords: vivo half; trybe free; half life; long vivo ... See more keywords